Our data demonstrate that PIM2 can further regulate glucose metabolism and drug resistance by changing the phosphorylation levels of specific PFKFB3 phosphorylation sites, thus showing that PIM2 is important in BC progression. Here, PIM2 is linked to breast cancer.